Kentucky Attorney General Russell Coleman announced that $19.8 million was awarded to 75 Kentucky organizations to combat the ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...
Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the acquisition of Banner Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results